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ABSTRACT We formulate a general analysis to determine the two-dimensional dissociation constant (2D Kd), and use this
method to study the interaction of CD2-expressing T cells with glass-supported planar bilayers containing ﬂuorescently labeled
CD58, a CD2 counter-receptor. Both CD2 and CD58 are laterally mobile in their respective membranes. Adhesion is indicated
by accumulation of CD2 and CD58 in the cell-bilayer contact area; adhesion molecule density and contact area size attain
equilibrium within 40 min. The standard (Scatchard) analysis of solution-phase binding is not applicable to the case of laterally
mobile adhesion molecules due to the dynamic nature of the interaction. We derive a new binding equation, B/F ¼ [(Nt 3 f)/(Kd
3 Scell)]  [(B 3 p)/Kd], where B and F are bound and free CD58 density in the contact area, respectively; Nt is CD2 molecule
number per cell; f is CD2 fractional mobility; Scell is cell surface area; and p is the ratio of contact area at equilibrium to Scell. We
use this analysis to determine that the 2D Kd for CD2-CD58 is 5.4–7.6 molecules/mm
2. 2D Kd analysis provides a general and
quantitative measure of the mechanisms regulating cell-cell adhesion.
INTRODUCTION
Cell membranes exert a powerful organizing inﬂuence on
biologically important chemical reactions, and this organiza-
tion is critically important for adhesive interactions. Proteins
that are wholly or partially embedded in cellular membranes
are conﬁned to diffuse laterally in two dimensions. Interac-
tions between proteins at the interface between two apposing
membranes are governed by two-dimensional reaction rates
and two-dimensional dissociation constants (1). Although
the chemical properties of these interactions are of great im-
portance, little experimental work has been performed focus-
ing on the chemical nature of these pro-adhesive molecular
interactions in the native membrane environment. In the
immune system, antigen-independent adhesive interactions
between T cells and antigen-presenting cells (APCs) are re-
quired before the interaction between T cell antigen receptors
and antigenic peptide-major histocompatibility complex
(MHC) protein complexes. Among the adhesion molecules
promoting the cell-cell interaction between T cells and APCs
are the T cell surface molecule CD2 and its widely expressed
counter-receptor CD58 (2,3). Other antigen-independent
adhesion molecules at the T cell surface are LFA-1, CD28,
the intercellular adhesion molecules (ICAMs), and CD80/
CD86 (4–8). Antigen-independent interactions not only en-
hance the strength of cell-cell adhesion but also provide
important costimulatory signals to the T cell (9–12). This
study focuses on the chemical nature of the CD2-CD58
binding interaction in the near two-dimensional interface
between a T cell and a model membrane. Importantly, we
develop a general methodology for dissecting the contribu-
tions of receptor afﬁnity and mobility to this dynamic in-
teraction.
CD2 and CD58 are members of the immunoglobulin
(Ig) superfamily of proteins. Each molecule consists of two
N-terminal Ig-like domains and a C-terminal membrane-
anchoring structure: CD2 is a transmembrane receptor with a
cytoplasmic tail, and CD58 has either a glycosylphosphati-
dylinositol (GPI) anchor or a transmembrane anchoring
domain (13). The extracellular domains of CD2 and CD58
are similar in size to those of the T cell antigen receptor
and the MHC proteins; both the CD2-CD58 and the T cell
receptor-MHC interactions are predicted to require an
intermembrane separation of;15 nm (14). This observation
suggests that adhesive interactions between CD2 and CD58
may be an ideal accessory for antigen recognition, thus in-
creasing the sensitivity of the latter process. The context
provided by coreceptors such as CD2-CD58 could be essen-
tial for the process by which a remarkably low number of
MHC-peptide complexes is required to trigger a T cell re-
sponse (15). Indeed, it is well known that the CD2-CD58
interaction increases the sensitivity of T cells to antigen (16).
Developing a quantitative model of the CD2-CD58 binding
interaction would be relevant to understanding the context of
fundamental antigen recognition processes.
The CD2-CD58 interaction has been well deﬁned in solu-
tion. The interaction is notable for its low afﬁnity (Kd esti-
mates range from 2 to 9–22 mM) and rapid dissociation rate
(koff . 5 s
1) (17–19). The relationship between the three-
dimensional Kd (3D Kd) measured in these studies and the
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two-dimensional Kd (2D Kd) that governs the interaction in
cell-cell contact areas is not obvious, however, because both
receptors and ligands are conﬁned to translate in only two
dimensions. We have therefore set out to analyze the 2D Kd
for the CD2-CD58 interaction directly, using as a model
system the interaction between T cells and a glass-supported
planar bilayer reconstituted with puriﬁed ﬂuorescently
labeled CD58. Accumulation of ﬂuorescent CD58 in the
contact area between T cell and bilayer is visualized by
ﬂuorescence microscopy, and radiolabeled antibody binding
is used to relate the ﬂuorescence intensity to molecular
surface densities. In previous studies, we have ﬁtted such
data using a simple Scatchard analysis (20,21). However, we
now introduce an analysis that accounts for the lateral
mobility of CD2 in the T cell membrane (22) and for the
accumulation of CD2 in the contact area between the T cell
and the bilayer. The dynamic nature of the CD2 receptor
density in the contact area during the equilibrium binding
measurement violates a fundamental assumption underlying
the Scatchard analysis. Here, we derive a general analysis of
the interaction between laterally mobile receptors at an
interface of two membranes. This analysis, which we have
termed the Zhu-Golan analysis, considers the accumulation
of both receptors and ligands within the contact area. We
apply this analysis to the CD2-CD58 system, and obtain
results that are strikingly different from those obtained using
the previous Scatchard analysis. Because many adhesion
molecules exhibit lateral mobility in cell membranes, our
general analysis provides a quantitative method for deter-
mining the physiologically relevant 2D Kd from dynamic
measurements of receptor-ligand interactions in single cells.
EXPERIMENTAL PROCEDURES
Cells and monoclonal antibodies
The Jurkat E6.1 T leukemia cell line (American Type Culture Collection,
Rockville, MD) was maintained in RPMI 1640 medium (Sigma, St. Louis,
MO) supplemented with 10% heat-inactivated fetal bovine serum (Sigma)
and 2 mM L-glutamine/100 units/mL penicillin/0.1 mg/mL streptomycin
(Sigma) at 37C in a humidiﬁed atmosphere of 5% CO2. Human peripheral
blood lymphocytes were puriﬁed as follows: Whole blood was layered in
Accuspin System-Histopaque-1077 centrifuge tubes (Sigma) and centri-
fuged at 2450 rpm (1000 3 g) for 10 min at 21C. Mononuclear cells
(MNCs) formed a single band at the Histopaque-plasma interface, while red
cells and granulocytes passed through the ﬁlter barrier and formed a pellet at
the bottom of the tube. MNCs were carefully aspirated using a Pasteur
pipette; this fraction contained .87% lymphocytes as assessed by Wright’s
staining and differential counting. MNCs were suspended in 20 mL of RPMI
1640 supplemented with 10% autologous plasma and the L-glutamine-
penicillin-streptomycin solution described above. Ten milliliters of cell
suspension was transferred to a 1003 20 mm culture dish and incubated for
24 h at 37C in a humidiﬁed incubator. The nonadherent cells were collected
by gently rocking the plate and centrifuged for 10 min at 1500 rpm (1003 g);
this procedure resulted in recovery of a 98% pure population of lymphocytes
in the cell pellet as assessed by Wright’s staining and conﬁrmed by im-
munophenotyping.
Anti-CD2 and anti-CD58 speciﬁc monoclonal antibodies (mAbs) were
produced from hybridoma culture supernatants. TS2/18 and 35.1 are
adhesion-blocking anti-CD2 mAbs (23); CD2.1 is a nonblocking anti-CD2
mAb (24); and TS2/9 is an adhesion-blocking anti-CD58 mAb (23).
Preparation of planar bilayer reconstituted
with FITC-CD58
GPI-CD58 was conjugated to ﬂuorescein isothiocyanate (FITC) as previously
described (20). To remove additional free FITC, the FITC-CD58 conjugate was
subjected to ultraﬁltration using a 30,000 MW cutoff membrane (Centricon,
Amicon, Beverly, MA) immediately after elution from the afﬁnity column.
Egg phosphatidylcholine (PC) (Avanti Polar Lipids, Alabaster, AL)
unilamellar liposomes were reconstituted with FITC-CD58, as described
(20). Glass-supported planar bilayers were formed by fusing egg PC lipo-
somes onto round glass coverslips (25 mm diameter, Fisher, Pittsburgh, PA).
Coverslips were boiled in detergent solution (Linbro 73, ICN Pharmaceu-
ticals, Costa Mesa, CA) for 30 min, washed with distilled water for 30 min,
and stored in 100% ethanol. For experiments, a coverslip was removed from
the ethanol and dried using argon, then a scratch was placed by a diamond
pencil at the center of the coverslip. This scratch helped to localize the focal
plane of the microscope at the bilayer. A liposome droplet (10–15 mL) was
deposited at the bottom of a plastic petri dish (503 9 mm), and the coverslip
was placed on top of the droplet with its scratched surface down. After a
30-min incubation, 3 mL of binding buffer containing 25 mM HEPES
(pH 7.4), 147 mM NaCl, 5 mM KCl, 0.8 mMMgCl2, 1.8 mM CaCl2, 5 mM
D-glucose, and 1% bovine serum albumin (BSA) (Calbiochem, San Diego,
CA) was added to the dish. The coverslip was released from the bottom of the
dish by gentle shaking. The coverslipwaswashed in binding buffer ﬁve times,
then the dish containing the coverslipwas immersed in a glass tank containing
1 liter of binding buffer. A stainless steel slide with a 15-mm diameter hole at
the center was engineered to mount the bilayer-bearing coverslip. The slide
was coated with vacuum grease on both sides around the hole, and a coverslip
was gently pressed on the grease to seal one side of the hole. The slide was
then placed into the tank with the opening of the hole facing up. The bilayer-
bearing coverslip was carefully placed on the other side of the metal slide,
with the bilayer face-down, and gently pressed on the grease to a ﬁrm seal. The
sandwich-like slide assembly was removed from the tank and rinsed with
distilled water. The nonbilayer coverslip was carefully slid off the opening to
add cells and/or reagents to the sample; this coverslip was then slid back and
pressed to seal the chamber again. Planar bilayers were never exposed to air.
The uniformity and continuity of the planar bilayer was conﬁrmed as
follows. When bilayers containing ﬂuorescein-labeled diacylphosphatidyl-
ethanolamine (Avanti Polar Lipids) were incubated with anti-ﬂuorescein mAb
(Molecular Probes, Eugene, OR), 48%of the ﬂuorescencewas quenched by the
antibody (data not shown). This observation, which indicated that approx-
imately half of the ﬂuorescent lipid molecules were capable of interaction with
the antibody while the other half were not, suggested that the membrane was a
unilamellar bilayer rather than a monolayer or a multilamellar structure.
Interestingly, FITC-labeled GPI-CD58 in the bilayer was completely quenched
by anti-FITC mAb (Sigma), suggesting that all of the GPI-CD58 (hereafter
called CD58) molecules were re-oriented to the upper leaﬂet of the bilayer (i.e.,
to the leaﬂet facing the aqueous solution) upon fusion of the liposomes into a
planar bilayer, and that all of the FITC-GPI-CD58 (hereafter called FITC-
CD58) in the bilayer would be capable of interaction with CD2 molecules
expressed on the surface of T cells. This informationwas important for accurate
determination of the effective free CD58 density in the bilayer.
Image analysis
Two-dimensional 180 3 180 mm ﬂuorescence images of FITC-CD58
redistribution in the egg PC bilayer were scanned using a step size of
0.6 mm. A scratch on the coverslip was used to focus the microscope
coarsely at the surface of the coverslip; the focus was then ﬁnely adjusted to
obtain the maximum ﬂuorescence intensity. Cellular autoﬂuorescence and
background ﬂuorescence was obtained by scanning the contact area between
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cells and a bilayer containing unlabeled CD58. To deﬁne the contact area,
the ﬂuorescence intensity threshold for each image was set equal to the sum
of the cellular autoﬂuorescence/background ﬂuorescence and the free FITC-
CD58 ﬂuorescence intensity (F), where Fwas measured from a cell-free area
of the bilayer. Contact area determinations using this method were generally
in good agreement with those determined using interference reﬂection
microscopy (25). The ﬂuorescence intensity was converted to an absolute
surface density of CD58 in the bilayer by using a standard curve of ﬂuo-
rescence intensity versus FITC-CD58 density. The standard curve was
obtained with bilayers prepared from vesicles containing FITC-CD58 at
a density that was measured using the 125I-labeled anti-CD58 mAb TS2/9.
Cellular autoﬂuorescence/background ﬂuorescence and free FITC-CD58
ﬂuorescence (F) were subtracted from the ﬂuorescence intensity in the cell-
bilayer contact area to yield the surface density of bound CD2-CD58
complexes (B). There was no detectable nonspeciﬁc binding of cells to
CD58-containing bilayers when the CD2-CD58 interaction was inhibited by
the adhesion-blocking anti-CD2 mAb TS2/18.
The assumption that, at equilibrium, the free FITC-CD58 density in the
contact area was equal to the (free) FITC-CD58 density outside the contact
area is an approximation that does not take into account the possible
reduction in free ligand density due to steric effects in the contact area. In
experiments on CD28-CD80 and CD2-CD58 interactions (26) (T. Starr and
M. L. Dustin, unpublished), a nonbinding GPI-anchored glycoprotein of
similar size to the ligand, but labeled with a different ﬂuorophore, was
included in the bilayer as a control for this effect. Imaging of the control
glycoprotein revealed a 20–40% reduction in free ligand in the contact area
compared to the surrounding bilayer. This correction was particularly
important at very high ligand density, where the amount of free ligand
excluded from the contact area could exceed the amount of ligand bound. In
this study, this correction would be very small due to the low density of free
ligand compared to the density of bound ligand, and it was therefore
unnecessary to apply the correction to the present data.
Confocal imaging of CD2 redistribution
Jurkat cells were incubated with the nonblocking, FITC-conjugated anti-
CD2 mAb, FITC-CD2.1 (100 mg/ml), in binding buffer for 30 min. After the
free antibody was removed by three washes, the cells were incubated for 40
min with a control bilayer (egg PC only) or a bilayer containing a high
density of CD58 (270 molecules/mm2). Confocal images were then taken, at
1-mm intervals in the z-axis, using an interactive laser cytometer with
confocal optics (Ultima, Meridian Instruments, Okemos, MI).
Fluorescence photobleaching recovery (FPR)
FPR was used to measure the fraction of laterally mobile CD2 molecules (f
value) and the lateral diffusion coefﬁcient of the mobile CD2molecules. Cell
surface CD2 molecules were labeled with FITC-CD2.1 on Jurkat T cell and
peripheral blood T cell membranes. FPR experiments were performed using
an interactive laser cytometer with confocal optics (Ultima, Meridian). The
protocol for FPR measurements has been described in detail (20,22); here,
the 250-mm emission pinhole was used to optimize z-axis resolution of the
upper and lower T cell membranes without losing signal intensity. CD2
mobility was measured in the cell-bilayer contact area by focusing on the
plane of most intense ﬂuorescence, as described above. CD2 mobility in the
membrane outside the contact area was measured by translating the focal
plane ;10 mm up from the plane of the bilayer to a region at the upper
surface of the cell. The average diameters of Jurkat T cells and peripheral
blood T cells were 11.1 and 7.0 mm, respectively.
Iodination of monoclonal antibodies
Protein A puriﬁed anti-CD2 mAbs TS2/18, 35.1 and CD2.1 were
concentrated to.1 mg/mL as determined by BCA assays (Pierce, Rockford,
IL), using bovine g-globulin as the standard. Antibodies (100 mg) were
iodinated using 1 mCi Na125I. Iodination was initiated with 1,3,4,6-
tetrachloro-3a,6a-diphenylglycouril coated glass tubes (2 mg per tube) by
the method of Fraker and Speck (27). Iodinated mAb was separated from
free iodide by gel ﬁltration, and active fractions were collected and pooled
without a carrier. The concentration of the active pools was determined by
BCA assay to allow accurate determination of speciﬁc activity.
Antibody binding assays
Jurkat T cells or peripheral blood T cells were washed twice with HEPES-
buffered saline containing 2% BSA, and resuspended to 5 3 106 cells per
mL. Cells were incubated with 2.3–230 nM iodinated mAb, in the presence
and absence of 1.33 mM cold antibody, for 1 h at 4C. TS2/18 and 35.1
mAbs displayed saturation binding to cells. Because this binding could have
represented bivalent or monovalent binding to cell surface CD2 molecules,
mAb molecular weights of 75,000 and 150,000 were used to calculate the
limits of a range of speciﬁc activities. Bound and free counts were separated
by centrifugation at 4000 3 g for 3 min through an oil cushion (1.5 parts
dibutylphthalate to 1 part dioctylphthalate (28)) in prechilled microsediment
tubes (Sarstedt, Newton, NC). The cell pellet and supernatant were separated
and counted. Scatchard analysis was used to calculate the average number of
CD2 sites per cell, as described (25).
Unless otherwise indicated, all experimental measurements were per-
formed at room temperature.
TWO-DIMENSIONAL ZHU-GOLAN ANALYSIS
Derivation of the two-dimensional Kd
The reaction of receptors (R) in a cell membrane with ligands
(L) in a planar bilayer can be described by the general
expression
R1 L4RL: (1)
At equilibrium,
½RL
½L ¼
½R
Kd
; (2)
where [RL], [L], and [R] are the densities of the receptor-
ligand complex, the free ligand, and the free receptor,
respectively, in the cell-bilayer contact area. Generally, in
Eq. 2
½R ¼ ½Rt  ½Rb; (3)
where [R]t is the density of total receptors and [R]b is
the density of bound receptors in the contact area. Because
[R]b ¼ [RL], we have
½R ¼ ½Rt  ½RL: (4)
Substitution for [R] in Eq. 2 results in
½RL
½L ¼
½R
t
Kd
 ½RL
Kd
: (5)
If [R]t is a constant, then Eq. 5 can be written in the
Scatchard form
B
F
¼ Bmax
Kd
 B
Kd
; (6)
and the Kd can be obtained from the negative reciprocal of
the slope of a B/F vs. B plot.
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Many cell surface receptors (such as CD2) are laterally
mobile in the cell membrane, however, and the migration of
these receptors into the contact area could result in variable
levels of accumulation depending on the ligand density in the
bilayer. In this case, [R]t in Eq. 5 is not a constant, but is
instead a function of the free ligand density (F). Therefore,
the Scatchard plot is not appropriate for analyzing the
binding of laterally mobile molecules.
To establish an equation describing the two-dimensional
binding equilibrium involving laterally mobile cell surface
receptors, we assume that, at equilibrium, the free receptor
density in the contact area is equal to the (free) receptor
density outside the contact area. Thus, [R] in Eq. 2 can be
expressed as
½R ¼ Nt3 f  ½RL3 Sb
Scell
; (7)
where Nt is the total number of receptors on the cell surface,
f is the fraction of laterally mobile receptors, Sb is the area of
contact, and Scell is the total surface area of the cell. Note that,
in this equation, only the laterally mobile receptors are con-
sidered to be capable of migration into the contact area to
interact with the ligand in the apposing membrane.
Substitution of Eq. 7 into Eq. 2 yields
½RL
½L ¼
Nt3 f
Kd3 Scell
 ½RL3 Sb
Kd3 Scell
: (8)
Let
p ¼ Sb
Scell
; (9)
and substitute B for [RL] and F for [L]. We then have the
Zhu-Golan equation
B
F
¼ Nt3 f
Kd3 Scell
 B3 p
Kd
: (10)
Note, in the ﬁrst term at the right side of Eq. 10, that the
constant Nt 3 f/Scell represents the mean density of laterally
mobile receptors. Thus, this term is not generally equivalent
to the Bmax for two-dimensional binding. For the three-
dimensional interaction (i.e., for the interaction between cell
surface receptors and soluble ligands), however, this constant
does reduce to Bmax, because for this case p¼ 1 (or Sb¼ Scell),
and Eq. 10 reduces to Eq. 6. In other words, the Scatchard
form in Eq. 6 is a special case of Eq. 10.
According to Eq. 10, the 2D Kd can be obtained from the
negative reciprocal of the slope of a B/F vs. B3 p plot. (Note
that the Scatchard form plots B/F vs. B.) At the x-intercept
(X), B/F ¼ 0 and Eq. 10 reduces to
Nt3 f
Scell
¼ B3 p: (11)
Thus, Nt can be calculated from the experimentally
determined values of f and Scell by using the expression
Nt ¼ X3 Scell
f
: (12)
The product Nt 3 f in Eq. 10 is equal to the total number
of laterally mobile receptors, or the maximum number of
receptors available for adhesion. Let
Bmax ¼ Nt3 f
Sb
: (13)
Equation 10 can then be written as
B
F
¼ ðBmax  BÞ3 p
Kd
: (14)
When B ¼ Bmax/2,
Kd ¼ F3 p: (15)
This result is analogous to that in the three-dimensional
analysis, in which Kd ¼ F at half-maximal binding.
Role of immobile receptors in the contact area
Although laterally immobile receptors are not capable of mi-
gration into the cell-bilayer contact area, a fraction of these
immobile receptors are present in the contact area from the
beginning of the cell-bilayer interaction. To consider the
potential contribution of these immobile receptors to ligand
binding, we assume that the binding afﬁnity of the immobile
receptors is identical to that of the mobile receptors. From
Eq. 5, the binding equilibrium can then be described by
BM1BI
F
¼ ½RM
Kd
1
½RI
Kd
; (16)
where BM and BI are the densities of bound mobile receptors
and bound immobile receptors in the contact area, respec-
tively, and [RM] and [RI] are the densities of free mobile
receptors and free immobile receptors in the contact area,
respectively.
Assuming that the density of immobile receptors is a
constant over the entire cell surface, [RI] can be calculated by
½RI ¼ Ntð1 f Þ
Scell
 BI: (17)
Combining Eqs. 7, 16, and 17 yields the general equation
for two-dimensional reactions involving both mobile and
immobile receptor populations,
B
F
¼ Nt
Kd3 Scell
 BM3 p1BI
Kd
; (18)
where B is the sum of BM and BI.
If all of the cell surface receptors are mobile, or if the
immobile receptors do not bind to ligands, then Eq. 10
provides an accurate description of the binding equilibrium.
Otherwise, Eq. 18 is a more accurate description of the
equilibrium when both mobile and immobile receptors
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contribute to ligand binding. However, since only total
binding (B) can be measured experimentally, a plot of B/F
vs. (BM 3 p 1 BI) is unachievable. Therefore, we use a plot
of B/F vs. (BM 1 BI) 3 p, or more simply
B
F
vs: B3 p; (19)
to determine the apparent two-dimensional Kd (Kd,app). The
potential error introduced by this approximation is addressed
in Appendix B.
RESULTS
Adhesion of T cells to bilayers reconstituted
with FITC-CD58
We used our analysis to measure the 2D Kd for binding
between CD2 receptors on Jurkat T cells and puriﬁed CD58
ligands in egg PC planar bilayers. The bilayers were re-
constituted with FITC-CD58 as described in Experimental
Procedures. The formation of CD2-CD58 complexes was
indicated by an increase in the ﬂuorescence intensity under
the cells and an increase in the cell-bilayer contact area, both
of which were due to accumulation of FITC-CD58 mole-
cules in the contact area (20,25). We ﬁrst investigated the
effect of CD58 density in the bilayer on cell adhesion (Fig.
1). Adherent cells could be differentiated from nonadherent
cells by visual inspection: when the microscope was gently
tapped, nonadherent cells drifted while adherent cells re-
mained ﬁrmly seated. Cell adhesion was also conﬁrmed by
interference reﬂection microscopy (25). We found that a
threshold CD58 density of 20 molecules/mm2 was required
for stable cell adhesion. A CD58 density of 40 molecules/
mm2 allowed .95% of cells to adhere to the bilayer (25).
Development of the cell-bilayer contact area
The size of the cell-bilayer contact area is one determinant of
adhesion strength. The contact area size was quantiﬁed as
described in Experimental Procedures. As shown in Fig. 2,
incubation of Jurkat T cells with CD58-reconstituted bilayers
resulted in a time-dependent increase in contact area, reach-
ing a steady-state value at ;40 min of incubation. The
contact area at steady-state was also found to be a function of
the initial density of FITC-CD58 molecules in the bilayer
(Fig. 3). No deﬁnitive contact was formed at initial CD58
densities ,20 molecules/mm2. At initial CD58 densities
.40 molecules/mm2, the steady-state contact area size
reached a plateau of 65 mm2/cell.
Accumulation of CD58 in the contact area
Laterally mobile CD58 molecules accumulated in the contact
area due to binding interactions with CD2 on the T cell
surface. Consistent with previous observations (20,25), the
accumulation required;40 min to reach a steady-state value
at all CD58 densities tested (Fig. 4). The time course of bound
CD58 accumulation (Fig. 4) was identical to that of contact
area development (Fig. 2), consistent with the interpretation
that formation of CD2-CD58 complexes in the contact area
provided the driving force for cell-bilayer adhesion. The
steady-state level of bound CD58 accumulation depended on
the initial density of CD58 in the bilayer (Fig. 5); nonlinear
least-squares analysis showed that this relationship had the
form of a saturable binding interaction with a maximum
accumulation of 760 CD2-CD58 complexes/mm2.
Accumulation of CD2 in the contact area
We also examined the formation of CD2-CD58 complexes
by measuring the accumulation of labeled CD2 molecules in
FIGURE 1 Jurkat T cell adhesion to CD58-containing bilayer, as a
function of the initial density of CD58 in the bilayer. Adherent and non-
adherent cells were scored as described in the text; at least 100 cells were used
for each data point. A threshold density of;20 molecules/mm2 was required
to support cell adhesion.
FIGURE 2 Development of the cell-bilayer contact area as a function of
incubation time. Jurkat T cells were incubated with bilayers containing
FITC-CD58 at a density of 100 molecules/mm2. The size of the contact area
was determined as described in the text; 30–100 cells were used for each
data point. Data points represent mean 6 SE.
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the contact area. In these experiments, the bilayers were
reconstituted with unlabeled CD58, and CD2 on the T cells
was labeled with FITC-CD2.1, a ﬂuorescent anti-CD2 mAb
that does not block CD2 binding to CD58. Confocal
microscopy was used to determine the distribution of CD2
on cells interacting with control (egg PC) and CD58-
containing bilayers. Cells resting on control bilayers showed
a uniform distribution of CD2 in the plasma membrane, with
no CD2 accumulation in the contact area. However, cells
adherent to bilayers containing CD58 showed substantial
redistribution of CD2 to the contact area (Fig. 6). The time
course of CD2 accumulation in the contact area was similar
to that of CD58 accumulation (not shown).
There was a direct relationship between the initial CD58
density in the bilayer and the steady-state level of CD2
accumulation in the contact area. The maximum density of
accumulated CD2 was fourfold greater than the initial CD2
density on the T cell surface (Fig. 7). (Note that Fig. 7 shows
the accumulation of total CD2 in the contact area, whereas
Fig. 5 shows the accumulation of bound CD58 in the contact
area. The accumulation of bound CD2 cannot be measured
in this experimental system, because the density of free
CD2 outside the contact area is difﬁcult to quantify on the
nonplanar membrane surface.) These important observations
conﬁrmed that CD2 density in the contact area was not a
constant, but was rather a function of the CD58 density in the
bilayer. These ﬁndings also supported the need for a new
analytical method to analyze the two-dimensional dissocia-
tion constant for binding of laterally mobile cell adhesion
molecules, since the standard Scatchard analysis assumes
that the density of receptor binding sites is invariant.
Lateral mobility of CD2
As noted above, we derived the 2D Kd analysis to account
for the lateral diffusion and accumulation of cell adhesion
molecules in the contact area. We used ﬂuorescence
photobleaching recovery (FPR) and confocal microscopy
techniques to measure directly the lateral mobility of CD2
in the plasma membranes of Jurkat T cells and peripheral
blood T cells. As shown in Table 1, CD2 molecules on
control Jurkat cells manifested a fractional mobility (f) of
0.75 6 0.04 (mean 6 SE) and a lateral diffusion coefﬁcient
of 7.96 1.03 1010 cm2 s1. These values were consistent
FIGURE 3 Size of the contact area as a function of initial CD58 density in
the bilayer. Jurkat T cells were incubated for 40 min with bilayers containing
different densities of FITC-CD58, and then contact area size was determined
as described in the text; 30–170 cells were used for each data point. Data
points represent mean6 SD. At initial CD58 densities,20 molecules/mm2,
cells were not adherent to the bilayer.
FIGURE 4 Time course of accumulation of bound CD58 molecules in the
contact area. The initial densities of CD58 in the bilayer were 24 (solid
circles), 50 (open circles), and 74 (solid triangles) molecules/mm2,
respectively. Bound CD58 molecules were quantiﬁed as described in the
text; 20–64 cells were used for each data point. Data points represent mean
6 SD.
FIGURE 5 Steady-state accumulation of bound CD58 molecules in the
contact area as a function of initial CD58 density in the bilayer. Jurkat T cells
were incubated for 40 min with bilayers containing different densities of
FITC-CD58, and then the density of bound CD2-CD58 complexes was
determined as described in the text. At least 50 cells were used for each data
point. Data points represent mean 6 SD.
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with previous reports (22). To measure CD2 mobility on
adherent cells, Jurkat cells were incubated with planar
bilayers containing CD58 at an initial density of 30
molecules/mm2. We chose a relatively low CD58 surface
density for these experiments to allow cell adhesion to the
bilayer while retaining a signiﬁcant number of laterally
mobile CD2 molecules outside the contact area. The f value
of CD2 outside the contact area was 0.756 0.06, which was
identical to the f value of CD2 in control cells (Table 1). The
fractional mobility of CD2 molecules in the contact area was
0.72 6 0.04 and the lateral diffusion coefﬁcient was 6.9 6
0.7 3 1010 cm2 s1. These data indicated that ligation of
CD2 by CD58 did not signiﬁcantly alter the lateral mobility
of CD2. The lateral mobility of CD2 on normal human
peripheral blood T cells was similar to that of CD2 on Jurkat
T cells, with an f value of 0.75 6 0.03 and a lateral diffu-
sion coefﬁcient of 5.7 6 0.5 3 1010 cm2 s1.
Determination of Nt by radiolabeled
antibody binding
The number of cell surface CD2 molecules on Jurkat T cells
and peripheral blood T cells (Nt) was determined by radio-
labeled antibody binding, using the anti-CD2 mAbs TS2/18
and 35.1 (see Experimental Procedures). The two antibody
assays yielded a range of Nt values from 43,000 to 86,000
CD2 molecules/cell for Jurkat T cells, and from 12,000 to
24,000 CD2 molecules/cell for peripheral blood T cells.
Normalizing for the calculated surface area of each cell type,
the average CD2 density was 60–120 molecules/mm2 on
Jurkat T cells and 43–86 molecules/mm2 on peripheral blood
T cells (see below).
Determination of 2D Kd and Nt by
Zhu-Golan analysis
According to Eq. 10, the 2D Kd for the CD2-CD58 binding
interaction can be obtained from plots of B/F vs. B 3 p.
Experimental values of B, F, f, and p were obtained as
described above. The surface area of the cells (Scell) was
calculated using the diameter of projected cell images and a
FIGURE 6 Confocal images of CD2 distribution on the surface of Jurkat
T cells. CD2 molecules were labeled using FITC-CD2.1, a ﬂuorescent
derivative of the nonblocking anti-CD2 mAb CD2.1. Cells were then
incubated with an egg PC bilayer (A) or with an egg PC bilayer that had been
reconstituted with 150 molecules/mm2 of unlabeled (i.e., nonﬂuorescent)
CD58 (B). Confocal microscopy was used to image sections in 1-mm steps
progressing from the bottom to the top of the cell, beginning from the glass
surface (A) or from 4 mm below the bottom of the cell (B); z values are
indicated relative to the plane of the coverslip in the upper right corner of
each section. There was no accumulation of CD2 at the area of contact with
bilayers lacking CD58 ((A), 0 to 13 mm), but cells interacting with bilayers
containing CD58 showed signiﬁcant redistribution of CD2 to the contact
area ((B), –2 to 11 mm).
FIGURE 7 Steady-state accumulation of CD2 molecules in the contact
area as a function of initial CD58 density in the bilayer. Jurkat T cells were
labeled with FITC-CD2.1, and then incubated for 40 min with bilayers
containing different densities of CD58. CD2 accumulation in the contact
area was determined as described in the text; 20–130 cells were used for each
data point. CD2 density in the contact area was normalized to the average
CD2 density on the surface of Jurkat cells; according to the data in Table 2,
this value was;136,000molecules/cellO 700mm2, or 190 molecules/mm2.
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surface roughness factor of 1.8 for the T cell (25,29). We
performed multiple measurements of CD2-CD58 binding
afﬁnity (see Fig. 8 for a representative Zhu-Golan plot), and
determined that the 2D Kd for this interaction was 7.6 6 0.9
molecules/mm2 for Jurkat T cells and 5.4 6 1.0 molecules/
mm2 for peripheral blood T cells (Table 2).
Our analysis also yields an estimate for the total number of
CD2 molecules per cell (Nt value). Nt was calculated using
Eq. 12 and the x-intercepts of the B/F vs. B3 p binding data
summarized in Table 2. According to this analysis, the
calculated number of CD2 sites was 136 6 4 3 103
molecules/cell for Jurkat T cells and 29 6 3 3 103
molecules/cell for peripheral blood T cells (Table 2). These
values were 20–60% larger than the Nt values determined
using radiolabeled antibody assays. This ﬁnding may reﬂect
the increased tendency of cells with a greater number of CD2
receptors to adhere to CD58-containing bilayers, which
would bias the Nt determination to higher values (25).
Finally, we considered the effect of immobile CD2
molecules on the 2D Kd and Nt measurements. Based on
this analysis (see Appendix B), the range of Kd,ideal values
was found to be 7.6–9.9 molecules/mm2 for Jurkat T cells
and 5.4–7.0 molecules/mm2 for peripheral blood T cells. The
overlap of these ranges with the 2D Kd determined using
Eq. 10 indicated that the small fraction of immobile CD2
molecules could be ignored without introducing signiﬁcant
error. Equation 35 was used to calculate Nt taking account of
the binding of immobile CD2 to CD58 in the contact area. The
Nt values determined using Eq. 35 were within 3–4% of those
calculated using Eq. 12, indicating that immobile CD2 re-
ceptors did not contribute signiﬁcantly to the Nt calculation.
DISCUSSION
The dynamic control of adhesive receptor-ligand interactions
is essential for a variety of important biological processes,
including immune synapse formation, lymphocyte migra-
tion, and cancer cell metastasis. We present here a method to
quantify three mechanisms that regulate the strength of cell-
cell adhesion: the number of adhesion receptors (Nt), the
fraction of laterally mobile receptors (f), and the receptor
afﬁnity for ligand (2D Kd). All of these mechanisms are
known to affect adhesive interactions; for example, the sur-
face density of both LFA-1 and ICAM-1 is increased upon
cytokine stimulation of cells (30–32), and changes in receptor
afﬁnity and lateral mobility control adhesion mediated by
LFA-1 or CD2 (32–38). Although these parameters are often
important features of quantitative models of cell adhesion
(39), experimental determination of their contributions to
adhesion has been difﬁcult (30–36,38). Using quantitative
ﬂuorescence imaging techniques and artiﬁcial bilayers of
deﬁned composition, we have developed a methodology
to quantify the roles of receptor-ligand afﬁnity, receptor
mobility, and receptor expression level in cell-cell adhesion.
TABLE 1 Lateral mobility of CD2
Jurkat T cells Peripheral blood T cells
D* [3 1010 cm2 s1] fy N D [3 1010 cm2 s1] f N
Control cellsz 7.9 6 1.0 0.75 6 0.04 23 5.7 6 0.5 0.75 6 0.03 33
Adherent cells§
Top of cell{ 6.7 6 0.7 0.75 6 0.06 18
Contact area 6.9 6 0.7 0.72 6 0.04 35
The ﬂuorescence photobleaching recovery (FPR) method is described in Experimental Procedures; data represent mean 6 SE.
*D, diffusion coefﬁcient.
yf, fractional mobility.
zThere was no CD58 in the bilayer.
§Cells were incubated for 30 min with bilayers containing CD58 (at an initial density of 30 molecules/mm2), and then FPR experiments were performed.
{The focus was ﬁrst oriented at the plane of the contact area, and was then moved 10 mm ‘‘up’’ along the z-axis.
FIGURE 8 Representative Zhu-Golan (B/F vs. B 3 p) plots (Eq. 10)
describing interactions of Jurkat T cells (open circles) and peripheral blood
T cells (solid circles) with bilayers containing CD58. Cells were incubated
for 40 min with bilayers containing different densities of FITC-CD58. The
densities of bound (B) and free (F) CD58 in the contact area, and the ratio of
contact area size to surface area of the cell (p), were then determined as
described in the text. Each point represents data from 27 to 176 cells. Curves
were analyzed to determine the 2DKd for the CD2-CD58 binding interaction
and the total number (Nt) of CD2 molecules on the T cell surface. For Jurkat
T cells, 2D Kd was 8.1 molecules/mm
2 (r2 ¼ 0.97) and Nt was 130,000
molecules. For peripheral blood T cells, 2D Kd was 7.4 molecules/mm
2 (r2¼
0.99) and Nt was 36,000 molecules.
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We have found that the initial density of CD58 in the
planar bilayer is an important parameter for the development of
adhesion. Production of a stable cell-bilayer adhesion requires
a minimum CD58 density of 20 molecules/mm2 (Fig. 1), sug-
gesting that a minimum number of initial bonds is required to
stabilize the adhesive interaction. In the physiological setting,
CD2-CD58 interactions are subjected to shear forces that could
shift this threshold. At CD58 densities greater than this
threshold value, both CD2 and CD58 accumulate at the cell-
bilayer interface; the contact area reaches a steady-state size
over a time course of 30–60 min (Fig. 2). The initial density of
CD58 in the bilayer determines both the contact area size and
the level of steady-state accumulation of CD2-CD58 com-
plexes in the contact area (Figs. 3–5).
Receptor accumulation in the contact area requires migra-
tion of the receptors to the site of adhesion, and therefore
depends on the lateral mobility of both CD58 in the bilayer
and CD2 on the cell surface. The lateral diffusion coefﬁcients
of CD58 and CD2 determine the kinetics of receptor migra-
tion and of contact area development. Because the diffusion
coefﬁcient of CD2 in the cell membrane (6–8 3 1010 cm2
s1) is approximately an order-of-magnitude less than that of
CD58 in the bilayer (20,25,40–42), it is likely that the lateral
diffusion of CD2 into the contact area is the rate-limiting step
for adhesion development.
The lateral diffusion of cell surface receptors is a critical
parameter for stable adhesion (40). Here, CD2 migration to
the contact area results in a signiﬁcant (up to fourfold) in-
crease in CD2 density at the site of adhesion (Fig. 7). This
dynamic property of the adhesion zone violates one of the
assumptions used in analyzing receptor-ligand interactions
by traditional (Scatchard) methods. We have therefore devel-
oped a new analysis to accommodate the dynamic nature of
the interaction involving laterally mobile cell surface re-
ceptors and ligands. Our analysis makes only one funda-
mental assumption: we assume that, at steady-state, the free
receptor density in the contact area is identical to the free
receptor density outside the contact area. Quantitative ﬂuo-
rescence microscopy and ﬂuorescence photobleaching re-
covery techniques are used to calculate the 2D Kd, total
receptor number (Nt), receptor lateral mobility (f), cell sur-
face area (Scell), and cell-bilayer contact area (Sb). Our model
can be used to analyze the three fundamental regulatory
mechanisms of cellular avidity modulation:
1. Altering the 2D Kd through a conformational change in
the receptor;
2. Changing the mobile fraction of the receptor (f) to pro-
vide for increased receptor accumulation in the contact
area; and
3. Altering the total receptor number (Nt) and thus the maxi-
mum number of potential bonds.
Moreover, the model reduces to the Scatchard form for the
special case where p equals 1 (see Eqs. 10 and 15), i.e.,
where the receptors over the entire surface of the cell are able
to participate in the interaction. Although p ¼ 1 in a case
such as the binding of soluble CD58 to cell surface CD2, for
any cell-cell adhesion event the receptor-ligand binding
interactions can occur only in the two-dimensional contact
area, for which p becomes 1. Therefore, our model is a
general analysis that is applicable to both two-dimensional
and three-dimensional interactions, while the Scatchard anal-
ysis is a special case of this model.
The factor p is the ratio of the contact area to the total cell
surface area. As shown in Fig. 3, p is also a function of CD58
density. Because the contact area size varies over a narrow
range for productive cell-bilayer adhesions (65–78 mm2/
cell), p is also conﬁned to a small range (0.094–0.112) and it
reaches a plateau at CD58 densities .40 molecules/mm2
(Fig. 3). Although our analysis implicitly treats the adhesion
zone as a uniform distribution of receptors, it is possible that
nonuniform patterns may contribute to the two-dimensional
afﬁnity in certain systems (43). The parameter f is the mobile
fraction of free receptor molecules on the cell. The confocal
FPR results (Table 1) indicate that 75% of CD2 molecules
are laterally mobile in resting T cells, and that ligation of
CD2 by CD58 in the contact area does not alter the f value.
From our results and analysis, we ﬁnd that f is the primary
determinant of the rate and the maximum extent of receptor
accumulation in the contact area.
TABLE 2 Results of binding analysis
Cell type Scell* [mm
2] pmax X Kd [mol/mm
2] Kd,ideal
y [mol/mm2] Nt
z [mol/cell 3 103]
Jurkat T cells{
Mean 700 0.100 6 0.005 145 6 5 7.6 6 0.9 7.6–9.9 136 6 4
Range — 0.094–0.112 138–156 5.6–9.2 — 129–146
Peripheral blood T cells§
Mean 280 0.109 6 0.004 78 6 7 5.4 6 1.0 5.4–7.0 29 6 3
Range — 0.082–0.121 44–100 2.5–10.2 — 17–38
*Mean cell surface area was calculated using the expression, Scell ¼ 4pr2 3 1.8, where r was the mean measured radius of the cells and 1.8 was a correction
factor for the roughness of the T cell (29).
yMean Kd,ideal was calculated using a @max value of 0.23 in Eq. 31 for both Jurkat T cells and peripheral blood T cells.
zNt was calculated using Eq. 12. Calculation of Nt using Eq. 35 yielded values within 3–4% of those using Eq. 12.
{Results represent mean, mean 6 SE, and range of values from three independent determinations on Jurkat T cells.
§Results represent mean, mean 6 SE, and range of values from determinations on peripheral blood T cell samples from eight different individuals.
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Because it is experimentally difﬁcult to measure sepa-
rately the binding of mobile and immobile receptors, the
determination of 2D Kd,ideal is challenging. Therefore, we
have used an approximation to determine the 2D Kd. The
general equations (Eqs. 16–18) assume that the mobile and
immobile receptors have the same afﬁnity for ligand. As we
demonstrate in Appendix B, the deviation caused by this
assumption is quite small. Equations 32 and 33 show that the
range of Kd,ideal values is a function of f; when f ¼ 50%,
Kd,app is well within this range. Moreover, f has a minimal
effect on the calculation of Nt, and this effect can be cal-
culated using Eq. 35.
The analysis used here allows determination of the
physiologically relevant 2D Kd. For the CD2-CD58 interac-
tion, the 2D Kd is 5.4–7.6 molecules/mm
2. Importantly, this
2D Kd value is similar between Jurkat T cells and peripheral
blood T cells, even though the total number of CD2 mole-
cules on the Jurkat cell line is;4–5-fold greater than that on
peripheral blood T cells (Table 2). The surface density of
CD2 is similar on the two cell types (i.e., Nt/Scell ¼ 100–190
molecules/mm2). The measured 2D Kd suggests that the
formation of CD2-CD58 bonds between T cells and antigen-
presenting cells (APCs) is highly favored at steady state.
Rearrangement of Eq. 2 allows estimation of a lower limit for
the ratio of bound to unbound CD2 receptors (RL/R) at the
T cell-APC contact, based on the 2D Kd for the interaction
and the initial CD58 site density on APCs. The initial CD58
site density, which ranges between 60 and 90 molecules/mm2
(44), predicts that the ratio of bound to unbound CD2 is
$8–12 in Jurkat cells and$11–16 in peripheral blood T cells.
These values would suggest that at least 88–94%of CD2mol-
ecules at the contact area are engaged in adhesive interac-
tions at steady state.
Utilizing the same Zhu-Golan analysis method, we have
previously used the adhesion of Jurkat cells to supported
planar bilayers to obtain a value of 1.1 molecules/mm2 for the
2D Kd of the CD2-CD58 interaction (25). Several experi-
mental differences are likely to have contributed to the
disparity between this value and the value obtained in this
study. These differences include the method used to measure
contact area size; the choice of blocking conditions; and the
Jurkat clone used in the study. Here, we used the ﬂuores-
cence of accumulated FITC-CD58 to deﬁne the contact area,
whereas previous determinations used interference reﬂection
microscopy (IRM). The ﬂuorescence intensity threshold
method requires that the membranes are within 15 nm for the
CD2-CD58 interaction, whereas the IRM method requires
that the membranes are less than a quarter wavelength apart
(;130 nm for green light). The two methods may therefore
report different contact area sizes, although both methods are
acceptable for this determination. Since the contact area sizes
measured here are ;1.5-fold larger than those measured by
IRM, a similar magnitude of increase would be expected in
the 2D Kd according to Eq. 10. Our earlier study also utilized
nonfat dry milk rather than BSA to block nonspeciﬁc binding
of cells to the bilayer. In other studies, we have found that
use of nonfat dry milk decreases nonspeciﬁc lymphocyte-
bilayer adhesion that emerges after speciﬁc interactions
induce formation of a contact area, and thereby facilitates
processes such as rapid cell migration (45). Interestingly,
reduction of bilayer-bilayer interactions after speciﬁc adhe-
sion would allow the dimensions of the CD2-CD58 inter-
action to determine the intermembrane spacing, resulting in a
higher two-dimensional afﬁnity due to greater conﬁnement.
We have used BSA here because it is better deﬁned than
nonfat dry milk, and our adhesion data suggest that Jurkat
cell interactions with the bilayer are both speciﬁc and de-
pendent on CD58 density (Fig. 1). The Jurkat clone used
here is also different from that used in our previous exper-
iments, and variability in Jurkat clones could contribute to
the discrepancy in the 2D Kd measurements. Hahn et al. have
suggested that cell activation inﬂuences the avidity of
adhesion mediated by the CD2-CD58 interaction (34), and
we have recently found that activation of the Jurkat clone
used here induces a 2.5-fold enhancement in the two-
dimensional afﬁnity of CD2-CD58 (46). It is possible that
the Jurkat clone used in our earlier study manifested a more
activated phenotype than the clone used here. Comparing our
earlier result with the ﬁndings presented here, we favor the
lower afﬁnity (7.6 molecules/mm2) measured here as the 2D
Kd for the CD2-CD58 interaction in resting Jurkat cells, as it
is supported by a direct comparison to the analogous mea-
surement in peripheral blood T cells (Table 2).
To achieve a quantitative understanding of cell surface
avidity regulation, new methods are required that measure
the parameters affecting cell-cell adhesion. We have de-
signed a system for quantitative monitoring of receptor-
ligand interactions at two-dimensional interfaces, and have
employed a new model to analyze the data in terms of a 2D
Kd. This analysis should be useful for dissecting the speciﬁc
mechanisms of avidity regulation used by a number of
different immune cell adhesion molecules. In this work, we
ﬁnd that a threshold density of CD2-CD58 binding interac-
tions is required for the stable adhesion of resting T cells. We
show that the 2D Kd of the CD2-CD58 interaction is 5.4–7.6
molecules/mm2 in both Jurkat T cells and peripheral blood T
cells. Our analysis provides a general method for discerning
the contribution of two-dimensional receptor afﬁnity to
adhesive interactions, and could be particularly useful in
characterizing systems that undergo conformational changes
resulting in afﬁnity modulation. It is well known, for ex-
ample, that cell stimulation modulates the avidity of
receptors including CD2 and LFA-1 (33,34,42). By using
our method to determine the 2D Kd, the roles of receptor
afﬁnity and mobility (clustering) in these interactions could
be separated. Explicit incorporation of these quantitative
measures of two-dimensional afﬁnity should also be of
interest for new models that include the contributions of
receptor ﬂexibility and conformational changes to adhesive
interactions (47). As alluded to above, we have recently
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reported the results of studies examining the effect of cell
activation on the parameters that regulate adhesion mediated
by the CD2-CD58 interaction (46).
APPENDIX A: NOMENCLATURE
See Table 3 below.
APPENDIX B: MODEL VALIDATION
At a given B/F, the difference (D) between the values of (BM 3 p1 BI) and
(BM 1 BI) 3 p is
D[ ðBM3 p1BIÞ  ðBM1BIÞ3 p ¼ BIð1 pÞ: (20)
The maximum values of BM (BM,max) and BI (BI,max) are deﬁned by
BM;max ¼ Nt3 f
Sb;max
(21)
and
BI;max ¼ Ntð1 f Þ
Scell
; (22)
respectively, where Sb,max is the maximum contact area at Bmax. Therefore,
the maximum D (Dmax), i.e., the difference between the x-intercepts of the
two plots at B/F ¼ 0, is deﬁned by Eqs. 20–22:
Dmax ¼ BI;maxð1 pmaxÞ ¼ Ntð1 f Þð1 pmaxÞ
Scell
: (23)
Let
@max[
Dmax
ðBM;max3 pmax1BI;maxÞ; (24)
i.e., @max represents the maximum fractional deviation of B3 p from (BM3
p 1 BI). Combining Eqs. 20–24, we have
@max ¼ ð1 f Þð1 pmaxÞ: (25)
This analysis is described graphically in Fig. 9, where Line A represents
B/F vs. B 3 p, with an x-intercept of Xa. (Note that the actual curve, as
shown by the dotted line, should deviate from the linear approximation,
particularly in the region of small B3 p values.) Line B is an imaginary line
parallel to Line A and separated from Line A by Dmax in the x direction.
Line C, the imaginary ideal plot of B/F vs. (BM 3 p 1 BI), lies between
Line A and Line B. X is the x-intercept of both Line B and Line C. Ya, Yb, and
Yc are the y-intercepts of Line A, Line B, and Line C, respectively, in the
order
Ya, Yc, Yb: (26)
Let
d[
Kd;ideal  Kd;app
Kd;ideal
; (27)
TABLE 3 Glossary of symbols
Symbol Deﬁnition Units Measurement*
B Bound ligand density in contact area [molecules/mm2] (FLcontact  FLbilayer  FLautoﬂuor) O speciﬁc
activity [FL/molecule].
Bmax Maximum bound ligand density in contact area [molecules/mm
2]
F Free ligand density (assumed to be equal in and out
of contact area)
[molecules/mm2] FLbilayer O speciﬁc activity [FL/molecule].
[R] Density of free receptor in contact area [molecules/mm2]
[L] Density of free ligand in contact area [molecules/mm2]
[RL] Density of receptor-ligand complex in contact area [molecules/mm2]
[R]t Density of total receptors [molecules/mm
2]
[R]b Density of bound receptors [molecules/mm
2]
[RM] Density of free mobile receptors [molecules/mm
2]
[RI] Density of free immobile receptors [molecules/mm
2]
BM Density of bound mobile receptors [molecules/mm
2]
BI Density of bound immobile receptors [molecules/mm
2]
Kd,ideal Ideal dissociation constant [molecules/mm
2]
Kd,app Apparent dissociation constant [molecules/mm
2] Negative reciprocal slope of B/F vs. B 3 p plot.
Nt Total number of CD2 molecules per cell [molecules/cell] Iodinated IgG or Fab binding; (X 3 Scell)/f.
Nb Total number of bound ligand molecules [molecules/contact] B 3 Sb.
Scell Surface area of cell [mm
2] 4pr2 3 1.8, where r is the measured radius of
the cell (see Results).
Sb Size of contact area [mm
2] Interference reﬂection microscopy (IRM);
ﬂuorescence intensity threshold method
(see Experimental Procedures).
Sb,max Maximal size of contact area [mm
2]
p Sb O Scell
f Fractional mobility [%] Fluorescence photobleaching recovery (FPR).
dmax Maximal fractional deviation of B 3 p
X x-intercept
Y y-intercept
*For additional experimental details, see references (20,25).
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where Kd,ideal represents the ideal Kd corresponding to Line C, Kd,app
represents the approximate Kd obtained from Line A, and d is the fractional
deviation of Kd,app from Kd,ideal. From Eqs. 24, 25, and 27,
@max ¼ X  Xa
X
(28)
and
d ¼
X
Yc
 Xa
Ya
X
Yc
,
X
Yc
 Xa
Yc
X
Yc
¼ X  Xa
X
¼ @max (29)
or
d, @max: (30)
Therefore,
Kd;app,Kd;ideal ¼ Kd;app
1 d,
Kd;app
1 @max; (31)
or
Kd;app,Kd;ideal,
Kd;app
1 ð1 f Þð1 pmaxÞ: (32)
According to Eq. 32, the range of Kd,app is deﬁned by the experimental
values of f and pmax. For example, when f ¼ 0.5 and pmax ¼ 0.1, Kd,app ,
Kd,ideal , 1.8 3 Kd,app.
In general, pmax  1 and Eq. 32 can be simpliﬁed to
Kd;app,Kd;ideal,
Kd;app
f
: (33)
Finally, we consider the contribution of immobile receptors to the estimate
of total receptor number described by Eq. 12. From Eqs. 18, 23, and 25, we
have
Nt ¼ ðBM;max3 pmax1BI;maxÞ3 Scell
¼ ðXa1DmaxÞ3 Scell
¼ Xa3 Scell1Dmax3 Scell
¼ Xa3 Sb;max1Ntð1 f Þð1 pmaxÞ: (34)
Therefore,
Nt ¼ Xa3 Scell
1 ð1 f Þð1 pmaxÞ: (35)
When pmax 1, Eq. 35 is nearly identical to Eq. 12. Therefore, we conclude
that the effect of an immobile receptor population is minor in our
experimental system. Models that include an explicit treatment of the
immobile receptor fraction have reached similar conclusions, ﬁnding no
major deviations from the analysis reported here (48).
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